Correlation Between Novo Nordisk and CSL

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and CSL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and CSL into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and CSL, you can compare the effects of market volatilities on Novo Nordisk and CSL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of CSL. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and CSL.

Diversification Opportunities for Novo Nordisk and CSL

-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Novo and CSL is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and CSL in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CSL and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with CSL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CSL has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and CSL go up and down completely randomly.

Pair Corralation between Novo Nordisk and CSL

Considering the 90-day investment horizon Novo Nordisk AS is expected to generate 1.21 times more return on investment than CSL. However, Novo Nordisk is 1.21 times more volatile than CSL. It trades about 0.03 of its potential returns per unit of risk. CSL is currently generating about -0.12 per unit of risk. If you would invest  12,755  in Novo Nordisk AS on February 1, 2024 and sell it today you would earn a total of  76.00  from holding Novo Nordisk AS or generate 0.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Novo Nordisk AS  vs.  CSL

 Performance 
       Timeline  
Novo Nordisk AS 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Novo Nordisk AS are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Novo Nordisk may actually be approaching a critical reversion point that can send shares even higher in June 2024.
CSL 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CSL has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong essential indicators, CSL is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Novo Nordisk and CSL Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novo Nordisk and CSL

The main advantage of trading using opposite Novo Nordisk and CSL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, CSL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CSL will offset losses from the drop in CSL's long position.
The idea behind Novo Nordisk AS and CSL pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio